Penn Capital Management’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-276,378	Closed	-$12M	–	228
2019 Q2	$12M	Sell	276,378 -13,434	-5%	-$570K	1.19%	15
2019 Q1	$11M	Buy	289,812 +65,073	+29%	+$2.54M	1.07%	26
2018 Q4	$12.3M	Sell	224,739 -40,516	-15%	-$1.89M	1.22%	17
2018 Q3	$16.4M	Sell	265,255 -76,325	-22%	-$3.3M	1.25%	13
2018 Q2	$11M	Sell	341,580 -50,935	-13%	-$1.76M	0.82%	51
2018 Q1	$12.3M	Buy	392,515 +58,218	+17%	+$2.07M	0.97%	33
2017 Q4	$15.4M	Buy	334,297 +59,455	+22%	+$2.36M	1.07%	18
2017 Q3	$10.4M	Buy	274,842 +32,549	+13%	+$1.31M	0.76%	54
2017 Q2	$11.6M	Buy	242,293 +235,615	+3,528%	+$10.9M	0.86%	47
2017 Q1	$325K	Buy	+6,678	New	+$289K	0.02%	257